Skip to main content

Table 1 Comparison between group I (control group) and group II (case group) regarding cure rate after treatment

From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

Cure Group I Group II Test value* p value
No. = 50 No. = 41
Complete 50 (100.0%) 39 (95.1%) 2.494 0.114
Relapse 0 (0.0%) 2 (4.9%)
  1. *Chi-square test